Bayoud, Y., Ménard, J., & Staerman, F. (2010). UP-2.34: Impact on quality of life of botulinum toxin-a in non-neurogenic detrusor overactivity refractory to anticholinergics. Urology, 76, S91. https://doi.org/10.1016/j.urology.2010.07.268
Chicago Style (17th ed.) CitationBayoud, Y., J. Ménard, and F. Staerman. "UP-2.34: Impact on Quality of Life of Botulinum Toxin-a in Non-neurogenic Detrusor Overactivity Refractory to Anticholinergics." Urology 76 (2010): S91. https://doi.org/10.1016/j.urology.2010.07.268.
MLA (9th ed.) CitationBayoud, Y., et al. "UP-2.34: Impact on Quality of Life of Botulinum Toxin-a in Non-neurogenic Detrusor Overactivity Refractory to Anticholinergics." Urology, vol. 76, 2010, p. S91, https://doi.org/10.1016/j.urology.2010.07.268.